Navigation Links
NVA237 Phase III GLOW2 Data at American Thoracic Society (ATS) International Conference and Phase II Clinical Trial Update
Date:5/16/2012

TOKYO, May 17, 2012 /PRNewswire/ --

  • GLOW2 study showed NVA237 superior to placebo and similar to OL tiotropium in increasing lung function, improving COPD symptoms and reducing exacerbations
  • Results demonstrated that once-daily NVA237 had rapid onset of action at first dose, sustained 24-hour bronchodilation, and was well tolerated over 52 weeks
  • NVA237 submitted forEU approval under proposed brand name Seebri® Breezhaler®. CHMP decision anticipated in 2012. In Japan, NDA submitted in November 2011. US filing expected in 2014

Sosei Group Corporation ("Sosei"; TSE Mothers Index: 4565) confirms the information released today by Novartis that results from the pivotal Phase III GLOW2 study demonstrated that once-daily (QD) 50 mcg NVA237 (glycopyrronium bromide) was superior to placebo in improving lung function, symptom relief and quality of life, and reducing exacerbations over a one-year period. The data will be presented at the 2012 American Thoracic Society (ATS) International Conference May 18-23, 2012 in San Francisco, CA, USA.

GLOW2 met its primary endpoint by demonstrating NVA237 provided superior 24-hour bronchodilation compared to placebo at 12 weeks measured by mean trough FEV1 (97 mL; p<0.001). At this same time point, trough FEV1 for open-label (OL) tiotropium was 83 mL versus placebo (p<0.001). In addition, NVA237 showed similar efficacy to OL tiotropium (Spiriva® HandiHaler®* Spiriva® HandiHaler® is a registered trademark by Boehringer Ingelheim Pharma Gmbh & Co. KG.
/18 mcg) in patients with moderate-to-severe chronic obstructive pulmonary disease (COPD). NVA237 also demonstrated rapid onset of action (within five minutes at first dose) and su
'/>"/>

SOURCE Sosei Group Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. NVA237 Filed in Europe and Positive Phase III Data at European Respiratory Society Congress
2. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
3. Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237
4. NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium
5. Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012
6. Inovio Pharmaceuticals Universal Avian Flu Vaccine Generates Protective Antibody Responses Against Six H5N1 Viruses in Phase I Trial
7. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
8. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
9. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
10. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
11. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2015)... 25. April 2015 Hospira, Inc. ... der Entwicklung von Biosimilar-Behandlungen, sprach heute auf der ... Generikaverbands (EGA) in London ... der Verfügbarkeit von Biosimilars für Patienten. ... White Papers mit dem Titel „Why extrapolation ...
(Date:4/24/2015)... 24, 2015  Perrigo Company plc ("Perrigo" or the ... the unsolicited offer from Mylan NV ("Mylan") (NASDAQ: ... of Perrigo for $60.00 per share in cash and ... (the "Offer").  The Board previously concluded ... undervalued the Company and its future growth prospects and ...
(Date:4/24/2015)... N.C. , April 24, 2015  New ... ability of consumers to educate themselves about products ... the tools and techniques available to market researchers ... the changing consumer marketplace, it,s imperative that organizations ... to better identify market opportunities, niches and growth ...
Breaking Medicine Technology:Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 2Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 3Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 4Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 5Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 6Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 7Führungskräfte von Hospira präsentieren auf bedeutendem europäischen Biosimilars-Forum - Ankündigung eines White Papers über Extrapolation 8Perrigo Rejects Mylan Unsolicited Offer 2Perrigo Rejects Mylan Unsolicited Offer 3Perrigo Rejects Mylan Unsolicited Offer 4Pharmaceutical Industry Using New Technologies to Adjust Their Marketing and Research Approaches for Consumers 2
... April 18, 2012  CAQH® announced today that ... the Universal Provider Datasource® (UPD®), demonstrating that ... standard for self-reported provider data used to ... network directories, referrals and claims administration. ...
... Live has revealed further details of the newest event ... (SEA) 2012. Set to debut from 10-12 May 2012 at ... first trade show and exhibition of its kind to be ... CPhI SEA will provide a meeting place ...
Cached Medicine Technology:One Million Healthcare Providers Now Use the CAQH Universal Provider Datasource 2One Million Healthcare Providers Now Use the CAQH Universal Provider Datasource 3Leading Pharma Ingredients Event Debuts in Growing ASEAN Market 2Leading Pharma Ingredients Event Debuts in Growing ASEAN Market 3
(Date:4/27/2015)... La Mirada, CA (PRWEB) April 27, 2015 ... various minimally invasive treatments for nail fungi and infections. ... believed to affect up to 10% of adults in ... discoloration, fragility, and irregularity in thickness. , ... Laser Institute , a branch dedicated to providing quality ...
(Date:4/27/2015)... Texas has saved $433 million by converting ... providing drug offenders with addiction treatment, according to an ... Several states, including Massachusetts, are considering adopting justice reinvestment ... formed community recovery programs to help redress rampant addiction ... State Governments WA, ID, NE, KS, MI, PA, ...
(Date:4/27/2015)... Consumer Choice Award is thrilled to announce the ... Ottawa. We would like to extend heartfelt congratulations to ... has resonated with the people of Ottawa. , Each ... and expectations through the responses of thousands of consumers ... selection process conducted by a third party research firm ...
(Date:4/27/2015)... The Sanford J. Grossman Charitable Trust, founded ... has committed $3 million to establish the Dr. Sanford ... Disease at the Icahn School of Medicine at Mount ... for treatment of Crohn’s disease, with the overarching goal ... a chronic inflammatory disorder of the bowel first described ...
(Date:4/27/2015)... CA (PRWEB) April 27, 2015 Final ... top of footage with ProTelestrator from Pixel Film Studios. A ... a freehand sketch over a moving or still video image. ... diagram and analyze sports plays or incoming weather patterns. , ... checkbox and then adjust the frame slider to control the ...
Breaking Medicine News(10 mins):Health News:Southern California Healthpointe Clinics Now Treating Nail Fungus 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 2Health News:Texas Saves $443 Million Embracing Justice Reinvestment for Drug Charges 3Health News:2015 Ottawa Consumer Choice Award-Winners 2Health News:2015 Ottawa Consumer Choice Award-Winners 3Health News:2015 Ottawa Consumer Choice Award-Winners 4Health News:2015 Ottawa Consumer Choice Award-Winners 5Health News:2015 Ottawa Consumer Choice Award-Winners 6Health News:2015 Ottawa Consumer Choice Award-Winners 7Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 2Health News:Sanford J. Grossman Charitable Trust Pledges $3 Million to Create Center at Mount Sinai 3Health News:Pixel Film Studios releases ProTelestrator for Final Cut Pro X. 2
... Rock and Roll Hall of Famer, Marky Ramone of the world-famous ... ... NEW YORK, Feb. 7 The American Social Health Association,(ASHA) recognizes ... sex practices have never been more critical. Despite,hundreds of millions of ...
... 19, 9 a.m. - 5 p.m.), SCOTTSDALE, Ariz., ... Dental Health Month. Dr. Lee Weinstein, a leading ... Associates for Kids Only, will be offering a Free Children,s ... until 5 p.m., The first 30 patients that call ...
... zebrafish in a bid to understand the causes of an ... team will use the model organism to investigate Lowe syndrome, ... a rare disorder that produces cataracts of the eyes, defects ... said Dr Martin Lowe, who will head the research. , ...
... react to stress may provide an important clue to ... reduce their painful effects, says Queens University Biology professor ... Robertson is using insect models to examine how the ... high temperatures and oxygen deprivation. They have discovered that ...
... Operations Research and the Management Sciences (INFORMS) today announced ... Edelman Award for Achievement in Operations Research and the ... , Reflecting the wide-ranging use of operations ... teams from Western Europe, and two federal agencies. , ...
... for Military Biomaterials Research (CeMBR), part of the New ... the development of a breakthrough spray-on dressing for injuries. ... medical device company in Norcross, Ga., received clearance for ... Feb. 1. , The GelSpray Liquid Bandage is a ...
Cached Medicine News:Health News:Beating to the Drum of Safe Sex 2Health News:Beating to the Drum of Safe Sex 3Health News:Free Children's Dental Day; Expert Source on Children's Dental Health Available 2Health News:Might fish provide Lowe-down on boyhood disease? 2Health News:Comatose locusts may help relieve migraines 2Health News:World's best analysts compete to win Edelman Prize in operations research and analytics 2Health News:Rutgers center sparks 'liquid bandage,' a new frontline wound treatment 2
Latex-free coronary artery perfusion/cardioplegia infusion cannulae....
... OXYPLETH is seven pounds of intelligent ... combined with software developed over 7 ... provides the ultimate in non-invasive oxygen ... oximeter monitor technology and sophisticated saturation ...
... Oximeter is a lightweight, portable console display module. ... two separate channels for up to one or ... as adjustable alarms for low and high limits ... user friendly and requires minimal training., ,Sensors of ...
... the Novametrix' family of capnography products. Along ... are the only handheld, mainstream capnographs available ... patient's airway condition and ventilatory status. Based ... capnographs, we miniaturized the size, not the ...
Medicine Products: